Seqirus

Organisation

Trials

  • NCT06279871

    Collaborator, Phase 3, Completed, 1,514 people, 28 Feb 2024

  • NCT06125691

    Collaborator, Phase 1, Completed, 139 people, 9 Nov 2023

Named in competing interests

Sources: pubmed.ncbi.nlm.nih.gov